Objective: To describe the distribution of immunoglobulins in the MS spinal cord and
relationship with neuropathological outcomes. Background: Cerebrospinal fluid-specific …

BACKGROUND: Recent findings support the important role of antibodies in multiple
sclerosis (MS) physiopathology. Thus, local IgG synthesis is a hallmark of the disease, and …

Objective: To present a case of spinal glioblastoma mimicking myelin oligodendrocyte
glycoprotein antibody disease (MOGAD). Background: Spinal cord lesions have a broad …

Objective: To assess whether patients' response to disease modifying therapies (DMT) in
multiple sclerosis (MS) varies by disease activity (annualised relapse rate, presence of new …

Objective: To evaluate risk factors in developing lymphopenia and hypogammaglobulinemia
in anti-CD20 treated MS patients. Background: Anti-CD20 treatment has been associated …

Objective: To quantify MRI predictors of disability progression and progression independent
of relapse activity (PIRA) from patients with multiple sclerosis (MS) in an observational …

Objective: To determine on an example of multiple sclerosis (MS) if cerebrospinal fluid (CSF)
signatures of complex neurological diseases allow their reliable differentiation from …

Objective: To describe treatment patterns among newly diagnosed patients with multiple
sclerosis (MS) by race and ethnicity. Background: Current treatment guidelines recommend …

distinctive IgG-mediated pathogenesis for primary progressive multiple sclerosis? | Brain |
Oxford Academic Skip to Main Content Advertisement Oxford Academic Journals Books Search …

Objective: To report the spectrum of MOG-Ab-associated syndromes in children Background:
Myelin oligodendrocyte glycoprotein antibodies (MOG-Ab) have been mainly associated …